Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis

NCT06735924 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT06735924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06735924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis
Lead sponsor
University of Alabama at Birmingham
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 26, 2023
Completion date
December 31, 2027
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

masld, metabolic dysfunction-associated steatotic liver disease